Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health

Type

Research/project funding

Posted on

28 October 2022

Application Deadline

05 September 2025

Reference Number

PAR-23-032

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Categories: Health.

More Information

Visit Website

Type

Research/project funding

Posted on

28 October 2022

Application Deadline

05 September 2025

Reference Number

PAR-23-032

Turn On Deadline Reminders

, United States

late-stage translation
arthritis
allowed
musculoskeletal
biomedical
academic non-profit lab
behavioral research result

Also Interesting

Research/Project Funding Opportunity

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Research/Project Funding Opportunity

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Research/Project Funding Opportunity

Notice of Change: NINDS Participation in PAR-24-131/PAR-24-133 "Small Business Transition Grant for New Entrepreneurs" (R43/R44 Clinical Trial Not Allowed)/(R41/R42 Clinical Trial Not Allowed)

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

Research/project funding

28 October 2022

05 September 2025

PAR-23-032

Research/project funding

28 October 2022

05 September 2025

PAR-23-032

Also Interesting

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Notice of Change: NINDS Participation in PAR-24-131/PAR-24-133 "Small Business Transition Grant for New Entrepreneurs" (R43/R44 Clinical Trial Not Allowed)/(R41/R42 Clinical Trial Not Allowed)